LAVIOLETTE PAUL A 4

What Happened
Paul A. Laviolette, a director of Edwards Lifesciences Corp (EW), was granted 3,251 restricted stock units (RSUs) on May 8, 2026. The Form 4 reports the acquisition as an award (transaction code A) at a reported price of $0.00, so no cash changed hands at grant and the immediate transaction value is listed as $0.

Key Details

• Transaction date: May 8, 2026 (filed the same day).
• Security: 3,251 restricted stock units (RSUs) granted, reported at $0.00 per unit.
• Post-transaction shares owned: Not specified in this Form 4 (filing notes it reflects changes only).
• Vesting: Footnote states the RSUs were granted under the 2020 Nonemployee Directors Stock Incentive Program and will become 100% vested at the earlier of one year from the grant date or the issuer's next annual meeting of stockholders.
• Filing timeliness: The Form 4 was filed with the same report and transaction date (no late-filing indication).

Context
RSUs are awards that convert into shares only upon vesting; they do not typically represent immediately tradable shares. Grants to nonemployee directors are routine compensation and do not, by themselves, indicate insider buying or selling sentiment. This Form 4 only reports the grant-related change and does not enumerate other holdings the director may have.